Healthcare Industry Future Updates

Thursday, April 21, 2022

Diabetic Foot Ulcer Treatment Market Growth & Trends

The global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.2% during the forecast period. Rising prevalence of diabetes, increasing healthcare expenses, and rapidly growing geriatric population worldwide are some of the major factors driving the diabetic foot ulcer treatment market.

Diabetic foot ulcers are one of the most common foot injuries that is caused due to diabetes mellitus. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary therapeutic approach so as to avoid amputation. Among different types of treatment options available, biologics held the largest share in the diabetic foot ulcer treatment market in 2017. This can be attributed to strong revenue generated by growth factors that are prescribed worldwide for their ability to promote generation of new cells and achieve wound closure. Therapy devices and wound care dressings also offer significant commercial opportunity due to their cost-effectiveness, ease of availability, and wide use in combination with other treatments at every level of wound care management.

Among different ulcer types, neuro-ischemic ulcers led the market in 2017 with more than 50.0% market share due to higher patient population suffering from the ulcer type globally. North America represented the largest share in the global market in 2017 owing to rising prevalence of diabetes, growing geriatric cohort, increased investment in R&D of novel therapies, and developed healthcare facilities.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/diabetic-foot-ulcer-dfu-treatment-market

Diabetic Foot Ulcer Treatment Market Report Highlights

The biologics segment commanded the largest share in 2017 and is projected to retain its position through the forecast period, due to increased adoption and potential approvals of growth factors
North America dominated the DFU treatment market in 2017 due to well-established favorable healthcare reimbursements and infrastructure
Asia Pacific is expected to witness the fastest growth owing to expanding diabetes patient population driven by increasing healthcare expenses and growing geriatric cohort
The neuro-ischemic ulcers segment accounted for the leading share in 2017. It is likely to experience the fastest growth during the forecast period
The foam and alginate dressings, skin grafts, and negative pressure wound therapy segments are anticipated to exhibit significant CAGR over the forecast period
Some of the key players in this space are ConvaTec, Inc.; Acelity L.P. Inc.; 3M Healthcare; Coloplast A/S; Smith & Nephew Plc.; B. Braun Melsungen AG; Medline Industries, Inc.; Medtronic Plc.; Organogenesis, Inc.; Molnlycke Health Care AB; and BSN Medical GMBH.

Diabetic Foot Ulcer Treatment Market Segmentation

Grand View Research has segmented the global diabetic foot ulcer (DFU) treatment market on the basis of treatment, ulcer type, and region:

Diabetic Foot Ulcer (DFU) Treatment Outlook (Revenue, USD Million, 2016 - 2025)

Wound Care Dressings

Alginate Dressings
Hydrofiber Dressings
Foam Dressings
Film Dressing
Hydrocolloid Dressings
Surgical Dressings
Hydrogel Dressings

Biologics

Growth Factors
Skin Grafts

Therapy Devices

Negative Pressure Wound Therapy
Ultrasound Therapy

Antibiotic Medications
Others

Diabetic Foot Ulcer (DFU) Treatment Ulcer Type Outlook (Revenue, USD Million, 2016 - 2025)

Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers

Diabetic Foot Ulcer (DFU) Treatment Region Outlook (Revenue, USD Million, 2016 - 2025)

North America

U.S.
Canada

Europe

Germany
U.K.

Asia Pacific

Japan
China
India

Latin America

Brazil
Mexico

South Africa

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/diabetic-foot-ulcer-dfu-treatment-market/request/rs1

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Fabry Disease Treatment Market: Global Industry Analysis and Forecast to 2025

The global fabry disease treatment market size is estimated to reach a value of USD 3.12 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.6% during the forecast period. Rising cohort of Fabry disease, increasing adoption of novel therapies such as chaperone treatment, and potential approval of pipeline drugs including substrate reduction therapies and enzyme replacement therapies are providing a fillip to the market.

Fabry disease is a rare inherited lysosomal storage disorder caused by genetic mutation that interferes with function of alpha galactosidase enzyme. Fabry disease generally has a late onset with mild symptoms, due to which several patients are often undiagnosed. Standard of care for management of the disease is enzyme replacement therapy (ERT). Sanofi’s Fabrazyme and Shire’s Replagal are the only approved ERTs in the EU; however in the U.S., only Fabrazyme has been approved.

Focus of current clinical trials is to improve the safety and efficacy profile of ERTs and introduction of novel oral therapies that can eliminate the need for intravenous infusions. Recently, Amicus Therapeutics’ Galafold has been approved as the first oral chaperone therapy for the treatment of adults in the U.S., Canada, EU, Japan, Australia, Israel, and South Korea.

North America held the largest share in the Fabry disease treatment market in 2017, followed by Europe. The growth of the region can be attributed to higher adoption of novel therapies, favorable reimbursement policies, and better healthcare facilities. However, high cost of therapy with ERTs such as Fabrazyme is an impediment for the market in developing regions.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/fabry-disease-treatment-market

Further Key Findings From the Study Suggest:

Although the exact prevalence is unknown, Fabry disease affects approximately one in 40,000 males
The enzyme replacement therapy segment led the market with over 85.0% market share in 2017 due to strong sales of Fabrazyme and Replagal.
North America commanded the leading market share of more than 45.0% in the Fabry disease treatment market, followed by Europe, in 2017
APAC is likely to witness the fastest growth during the forecast period, followed by Latin America, due to increasing healthcare expenditure and rising patient population
Some of the key players in the market are Sanofi S.A.; Shire Plc.; Amicus Therapeutics Inc.; ISU Abxis Co Ltd.; JCR Pharmaceuticals Co Ltd.; Protalix Biotherapeutics Inc.; Idorsia Pharmaceuticals Ltd.; Avrobio Inc.; Greenovation Biotech GmbH; Moderna Therapeutics Inc.; and Green Cross Pharma Pte Ltd.

Grand View Research has segmented the global fabry disease treatment market on the basis of treatment and region:

Fabry Disease Treatment Outlook (Revenue, USD Million, 2016 - 2025)

Enzyme Replacement Therapy (ERT)
Chaperone Treatment
Substrate Reduction Therapy (SRT)
Others

Fabry Disease Treatment Region Outlook (Revenue, USD Million, 2016 - 2025)

North America

U.S.
Canada

Europe

Germany
U.K.

Asia Pacific

Japan
China
India

Latin America

Brazil
Mexico

South Africa

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/fabry-disease-treatment-market/request/rs1

About Grand View Research

For more info visit @ https://www.grandviewresearch.com

Cold Plasma Market: Global Industry Analysis and Forecast to 2026

The global cold plasma market size is expected to reach USD 198.50 million by 2026 at a strong CAGR of 15.2%, according to a new report by Grand View Research, Inc. Increasing use of cold plasma in medical treatment and rising cases of Hospital-Acquired Infections (HAI) are the key driving factors for the global market. In healthcare industry, plasma technology has been in use for some time and it continues to help improve various treatments. One of the major properties of cold plasma is the ability to kill bacteria and prevent infection. Therefore, it acts as an effective healing solution. It also accelerates healing process and prevent patient from discomfort.

Cold plasma is used in the treatment of chronic wounds and burns. The bacterial cells, including Multidrug Resistant (MDR) bacteria, are instantly killed after being exposed to cold plasma. As per an article published by the Medical Xpress, Med Tech Europe, around 4.0 million people in Europe suffer from non-healing wounds every year. It also reported that a burn patient in Germany was treated using prototype plasma treatment. Moreover, as per a research published by The National Center for Biotechnology Information (NCBI), a patient suffering with two second-degree burns was treated with cold plasma, which healed the itching and pain and presented new tissue after the second treatment. Such cases are anticipated to promote the usage of cold plasma in various wound treatments.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/cold-plasma-market

Cold Plasma Market Report Highlights

In terms of revenue, atmospheric pressure segment is projected to ascend at the fastest CAGR over the forecast period due to rising application scope in various medical procedures
Wound healing application segment is expected to witness a significant growth over the forecast period
Asia Pacific region is estimated to witness the highest growth due to increased adoption of technologically advanced procedures for treatment of various diseases
Rise in disposable income levels and growing target population base are also likely to contribute to the region’s development
Some of the key companies in the global cold plasma market are U.S. Medical Innovations, LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma N.V., and P2i Limited

Cold Plasma Market Segmentation

Grand View Research has segmented the global cold plasma market on the basis of pressure, application, and region:

Cold Plasma Pressure Outlook (Revenue USD Million, 2014 - 2026)

Low-Pressure Cold Plasma
Atmospheric Pressure Cold Plasma

Cold Plasma Application Outlook (Revenue USD Million, 2014 - 2026)

Wound Healing
Blood Coagulation
Dentistry
Cancer Treatment
Other Medical Applications

Cold Plasma Regional Outlook (Revenue, USD Million, 2014 - 2026)

North America

U.S.
Canada

Europe

U.K.
Germany

Asia Pacific

Japan
China

Latin America

Brazil
Mexico

Middle East and Africa

South Africa

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/cold-plasma-market/request/rs1

About Grand View Research

For more info visit @ https://www.grandviewresearch.com

Tuesday, April 19, 2022

U.S. Pharmacy Benefit Management Market Future Growth Analysis And Latest Trends

The U.S. pharmacy benefits management market size is projected to reach USD 744.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.2% during the forecast period. Increasing vertical integration of key market players, rising prevalence of chronic disease, and shrinking FDA generic-approval backlog are some of the primary growth stimulants for the market.

Vertical integration of pharmacy benefits management (PBM) organizations with health insurance companies are poised to result in increased control of PBMs over distribution systems. This will lead to rise in rebates, ultimately increasing the cost of drug list prices. Moreover, it will result in a monopoly of certain market player, concentrating sales and revenue generation.

The business of insuring and administering employee benefit programs in the country, especially, health care programs, is heavily regulated by federal and state laws and administrative agencies, such as the Department of Health and Human Services (HHS), State Departments of Insurance, Centers for Medicare & Medicaid Services (CMS), Internal Revenue Services, and Departments of Labor.

All PBM businesses in the U.S. must include home delivery and specialty pharmacies licensed as pharmacies in the states of establishment. Several states in the country regulate the scope of prescription (Rx) drug coverage and delivery channels to receive drugs for managed care organizations (MCOs), insurers, and Medicaid care plans. Certain home delivery and specialty pharmacies must be registered with the U.S. Drug Enforcement Administration (DEA) and individual state controlled substance authorities.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/us-pharmacy-benefit-management-pbm-market

Further key findings from the study suggest:

Based on business model, the market has been segmented into standalone PBM, health insurance providers, and retail pharmacy. Of these, PBMs associated with health insurers are likely to witness the fastest growth over the forecast period
Rise in mergers and partnerships between market players is expected to result in an increased demand for PBM systems
OptumRx and Express Scripts (merged with Cigna in December 2018) are among the key players merged or acquired by large health insurance providers
Based on end use, the market has been divided into commercial and federal. Commercial PBM systems dominated the market and are estimated to maintain their dominance through 2026 owing to a large number of covered patients
CVS Health; Aetna; Express Scripts; Cigna; OptumRx, Inc.; Walgreens Booth Alliance; MedImpact Healthcare Systems, Inc.; Anthem; and Rite Aid are some of the key players in the market.

Grand View Research has segmented the U.S. pharmacy benefits management (PBM) market based on business model and end use:

U.S. Pharmacy Benefit Management Business Model Outlook (Revenue, USD Billion, 2015 - 2026)

Standalone PBMs
Health Insurance Providers
Retail Pharmacy

U.S. Pharmacy Benefit Management End-use Outlook (Revenue, USD Billion, 2015 - 2026)

Commercial
Federal

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/us-pharmacy-benefit-management-pbm-market/request/rs1

About Grand View Research

For more info visit @ https://www.grandviewresearch.com

IoT in Healthcare Market: Global Industry Trends, Share, Size, Recent Growth

The global IoT in healthcare market size is projected to reach USD 534.3 billion by 2025 expanding at a CAGR 19.9% over the forecast period, according to a new report by Grand View Research, Inc. Rise in investments for the implementation of IoT solutions in healthcare sector is one of the key factors driving the market. Increasing penetration of connected devices in various healthcare institutes and adoption of IoT systems and software solutions in healthcare operational activities are also among the key factors augmenting the market growth.

Growing preference for real-time data monitoring among the healthcare practitioners to manage chronic diseases is expected to propel the demand for IoT network in healthcare institutions. Combinations of remote monitoring, mobile platforms, and analytics have cut the rate of readmissions of patients suffering from congestive heart failure, diabetes, and blood pressure. Furthermore, advancements in communication technologies, such as real-time data transmission, has positively impacted the patients in manage chronic diseases and medication dosage, which has further fostered the market growth.

For instance, connected wheelchairs allow people with disabilities to communicate health alerts to care teams and engage with care providers. Growing number of IoT platform installations for better and early diagnosis and disease tracking is also contributing to the market development. Furthermore, rising demand for digital technologies for managing diseases, such as insomnia, diabetes, autism, heart disease, and asthma, is also poised to spur the market growth.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/internet-of-things-iot-healthcare-market

IoT in Healthcare Market Report Highlights

In 2018, services held the largest revenue share owing to the high demand for improved decision-making in real-time and uninterrupted data flow between devices and people to uplift the efficiency of medical systems
Hospitals and clinics held the largest revenue share in 2018 due to increased investments by hospitals to encourage the usage of digital technologies
North America is expected to be the largest market owing to growing adoption of healthcare IT solutions and availability of sophisticated infrastructure in the region
Asia pacific expected to witness the fastest CAGR over the forecast period owing to growing investments by the pharmaceuticals & medical devices companies and increasing adoption of advanced technologies
Key companies operating in this market include Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Biotronik, and Boston Scientific

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/internet-of-things-iot-healthcare-market/request/rs1

About Grand View Research

For more info visit @ https://www.grandviewresearch.com

RFID in Healthcare Market Worth $10.65 Billion By 2025

The global rfid in healthcare market size is expected to reach USD 10.65 Billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 22.4% during the forecast period. Some of the key contributors to the growth include rising focus on reducing operational costs and streamline the workflow, demand for efficient supply chain management, and need to improve the quality and efficiency of care.

High operational costs associated with the healthcare industry is expected to boost the adoption of RFID technology in healthcare organizations. Pharmaceutical companies, medical device manufacturers, hospitals, and various other healthcare organizations integrate this technology to control inventory costs. RFID technology enables these organizations in efficient inventory management and help avoid stock out and overstock situations. RFID tags enable the surgical staff in easy tracking of medical devices used in operation theatres, thereby improving patient safety. Growing requirement for reduction in operating costs is expected to drive the increase in adoption of RFID. This technology is also used in laboratories, blood banks, and pathology labs for efficient product tracking and better workflow management.

The use of RFID technology enables better communication, adequate patient monitoring, patient identification, and patient tracking. This method aids in decreasing medication errors and increases safety. The rising need for patient monitoring and mandates for increasing safety are also contributing to the growth. Patient tracking across different hospital sections using this technology helps reduce waiting times and is thus gaining significance in hospitals.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/rfid-in-healthcare-market

Further key findings from the report suggest:

RFID tags product segment held majority of the market share in 2018 due to rising awareness regarding the benefits of these devices
Increasing use of tags for tracking various assets, patients, staff, pharmaceuticals, and donated blood is expected to boost the market during the forecast period
Pharmaceutical tracking application segment held the largest market share in 2018, owing to rising needs to identify counterfeit drugs and demand for inventory management
North America led the global market owing to increasing number of hospitals and presence of regulations on patient safety
Asia Pacific is anticipated to witness the fastest CAGR owing to the presence of a large pharmaceutical industry requiring this technology for process streamlining
Some of the key players operating in the RFID in healthcare market include LogiTag, CenTrak, SpaceCode, Impinj, Zebra Technologies Corporation, Biolog-id, Terso Solutions, Carinal Health, Mobile Aspects, Tagsys RFID, Pepperl+Fuchs, and metraTec GmbH

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/rfid-in-healthcare-market/request/rs1

About Grand View Research

For more info visit @ https://www.grandviewresearch.com

Sunday, April 17, 2022

Healthcare Supply Chain Management Market Business Growth, Development Factors, Applications, And Future Prospects 2025

The global healthcare supply chain management market size is expected to reach USD 3.4 billion by 2025, according to a new report by Grand View Research, Inc., registering an 8.7% CAGR during the forecast period. Growing adoption of GS1 standards and Unique Device Identification (UDI), emergence of cloud-based solutions for the healthcare industry, and increasing adoption of mobile-based supply chain management solutions are key factors contributing to market growth. Growing requirement for reduction in operating costs among healthcare organizations is another major factor positively impacting the market.

Increasing pressure encountered by healthcare providers to improve operational profitability and efficiency plays a vital role in increasing revenue growth. Growing demand to limit large-scale counterfeiting of drugs in the pharmaceutical industry is also boosting the growth of the market. Significant improvements in supply chain management solutions with respect to data security is fueled by changing health patterns of the population. According to CDC, half of the adult population in the U.S. has one or more chronic health conditions. This further helps in creating a more patient-centered supply chain that can be provided when and where patients need it.

Mobile apps have become an essential part of supply chain management solutions and logistic companies in developed as well as developing countries have begun relying on GPS-enabled mobile applications.There are several supply chain management apps available today. For instance, Curvo Labs designed a platform to upsurge supply chain efficiency by automating and modernizing supply chains in hospitals and healthcare organizations.

Market players such Oracle Corporation; SAP; Logi-Tag Systems; McKesson Corporation; Manhattan Associates; Tecsys; Infor Inc.; Global Healthcare Exchange (GHX); Jabil; and AmerisourceBergen are focused on increasing collaborations with other industry players to gain a competitive edge. Mergers and acquisitions and service differentiation are some of the other key strategies adopted by these companies to strengthen their market presence. For instance, in March 2019, Jump Technologies collaborated with X3 Consulting Group to streamline supply chain processes and mitigate risks for hospitals by implementing the Jump Stock software solution.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/healthcare-supply-chain-management-market

Healthcare Supply Chain Management Market Report Highlights

By product, software emerged as the largest segment in 2018 with a revenue share of 39.2%
Based on mode of delivery, the cloud-based segment accounted for the dominant revenue share in 2018. The segment is also expected to exhibit the fastest CAGR over the forecast period
On the basis of end use, healthcare manufacturers emerged as the leading segment. However, distributors are expected to register significant growth rate through 2025
North America accounted for the largest share due to rising patient burden in the U.S., implementation of various strategies to enhance healthcare supply chain management, and growing adoption of scanning technologies such as barcodes and RFID in the region
Asia Pacific is anticipated to exhibit a lucrative CAGR of 9.7% over the forecast period owing to increased implementation of technologically advanced solutions in countries such as, China, India, and Japan
Oracle Corporation; SAP; Tecsys; Infor Inc.; Manhattan Associates; Global Healthcare Exchange (GHX); Logi-Tag Systems; AmerisourceBergen; and Jabil are some of the leading players in the market.

Healthcare Supply Chain Management Market Segmentation

Grand View Research has segmented the global healthcare supply chain management market on the basis of product, mode of delivery, end-use, and region:

Healthcare Supply Chain Management Product Outlook (Revenue, USD Million, 2014 - 2025)

Software
Hardware

Barcodes
RFID Tags

Services

Healthcare Supply Chain Management Mode of Delivery Outlook (Revenue, USD Million, 2014 - 2025)

On-premise
Cloud-based
Web-based

Healthcare Supply Chain Management End-use Outlook (Revenue, USD Million, 2014 - 2025)

Healthcare Manufacturers
Healthcare Providers
Distributors
Logistics

Healthcare Supply Chain Management Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.
Canada

Europe

U.K.
Germany
France
Italy
Spain
Russia

Asia Pacific

China
Japan
India
Australia
Singapore
South Korea

Latin America

Brazil
Mexico
Argentina

Middle East & Africa

South Africa
Saudi Arabia
UAE

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/healthcare-supply-chain-management-market/request/rs1

About Grand View Research

For more info visit @ https://www.grandviewresearch.com